Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/Paraganglioma
Clinical trial NCT01967576 · COMPLETED
Trial details
- NCT number
- NCT01967576
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-19
- Primary completion
- 2015-06-29
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.